Alcohol dehydrogenase and cytochrome P450 2E1 can be induced by long-term exposure to ethanol in cultured liver HEP-G2 cells

. 2013 Sep ; 49 (8) : 619-25. [epub] 20130704

Jazyk angličtina Země Německo Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid23824954

It has been shown in previous studies that liver HEP-G2 cells (human hepatocellular carcinoma) lose their ability to express active alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1). Although both are ethanol-inducible enzymes, short-term exposure to ethanol does not cause any changes in expression or activity in cultured HEP-G2 cells. Therefore, we tested the effect of long-term exposure to ethanol on the expression and activity of both ADH and CYP2E1 in these cells. The expression of ADH and CYP2E1 was assessed at the mRNA and/or protein level using real-time PCR and Western blot analysis. Specific colorimetric assays were used for the measurement of ADH and CYP2E1 enzymatic activities. Caco-2 cells (active CYP2E1 and inactive ADH) were used as control cells. Significantly increased protein expression of ADH (about 2.5-fold) as well as CYP2E1 (about 1.6-fold) was found in HEP-G2 cells after long-term (12 mo) exposure to ethanol. The activity of ADH and CYP2E1 was also significantly increased from 12 ± 3 and 6 ± 1 nmol/h/mg of total protein to 191 ± 9 and 57 ± 9 nmol/h/mg of total protein, respectively. We suggest that the loss of activity of ethanol-metabolizing enzymes in cultured HEP-G2 cells is reversible and can be induced by prolonged exposure to ethanol. We are therefore able to reactivate HEP-G2 cells metabolic functions concerning ethanol oxidation just by modification of in vitro culture conditions without necessity of transfection with its side effect - enzyme overexpression.

Zobrazit více v PubMed

Arch Biochem Biophys. 1992 Nov 15;299(1):163-71 PubMed

Mol Cell Biochem. 2009 Jan;321(1-2):123-33 PubMed

Drug Metab Dispos. 2006 May;34(5):880-6 PubMed

Toxicol Appl Pharmacol. 2006 Oct 15;216(2):238-47 PubMed

J Pharm Pharmacol. 2009 May;61(5):541-58 PubMed

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):70-6 PubMed

Physiol Rev. 1997 Apr;77(2):517-44 PubMed

Semin Liver Dis. 2007 Feb;27(1):44-54 PubMed

Acta Chem Scand. 1969;23(3):892-902 PubMed

Biochim Biophys Acta. 2001 Sep 3;1514(1):117-26 PubMed

Chem Res Toxicol. 1991 Nov-Dec;4(6):642-7 PubMed

Hepatology. 1989 Oct;10(4):437-46 PubMed

Biochem Biophys Res Commun. 1994 Aug 30;203(1):727-33 PubMed

Hepatology. 1993 Feb;17(2):236-45 PubMed

Exp Biol Med (Maywood). 2010 Jan;235(1):32-9 PubMed

J Biol Chem. 1960 Nov;235:3188-92 PubMed

Hum Pathol. 2009 Oct;40(10):1512-5 PubMed

Xenobiotica. 1998 May;28(5):429-41 PubMed

Biochem Biophys Res Commun. 1993 May 28;193(1):47-53 PubMed

Cell Biol Toxicol. 2000;16(4):221-33 PubMed

Free Radic Biol Med. 2008 Mar 1;44(5):723-38 PubMed

Alcohol. 2004 Aug;34(1):9-19 PubMed

Blood Cells Mol Dis. 2006 Sep-Oct;37(2):95-9 PubMed

Scand J Gastroenterol. 2003 Nov;38(11):1154-61 PubMed

Br J Clin Pharmacol. 2005 Jul;60(1):54-60 PubMed

J Pharmacol Exp Ther. 1990 Apr;253(1):387-94 PubMed

Toxicol Sci. 2003 Jun;73(2):423-30 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...